Navan is perhaps the most high-profile IPO over the past month, as the SEC's filing process has stalled with 90% of staff furloughed.

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...

Navan's shares started trading 12% below their initial public offering price on Thursday, as the travel technology company ...

Shares in Princes Group made their debut on the London Stock Exchange on Friday, rounding off a rare, busy month of listings ...

OpenAI is preparing for a $1 trillion IPO that could launch in 2026. The ChatGPT maker plans to raise at least $60 billion ...

Discover how book building helps underwriters price IPOs effectively by gauging investor interest and demand. Learn why it's the preferred method over fixed pricing.

According to a filing with the Securities and Exchange Commission dated October 20, 2025, Renaissance Capital reported a new ...

Founded only nine months ago, the company plans to build a Texas-based 'HyperGrid' and become a provider of data and power ...

The trajectory of the Lenskart IPO GMP shows how exuberance has given way to caution, with the market asking for a bit more ...

Shares in British lender Shawbrook jumped as much as 8% in early Thursday trade following London's biggest initial public ...

As Navan positions itself as an AI-driven solution for corporate travel, its founders are cashing in on some of their shares ...

Picard Medical stock plunged approximately 65% in premarket trading on Friday, collapsing from its recent 52-week high of $13 ...